|
Yahoo! News: Health News
|
Health News
|
|
-
U.S. medical programs missing millions of kids: report
(Reuters)
Reuters - An estimated five million uninsured children in the United States were eligible for Medicaid or the Childrens Health Insurance Program (CHIP) but were not enrolled in either plan, according to a new report.
-
Seniors Get Boost From Bad News About the Young
(HealthDay)
HealthDay - THURSDAY, Sept. 2 (HealthDay News) -- Older people prefer to read
negative news stories about the young, possibly because it makes them feel
better about themselves, a new study suggests.
-
Can home cooking be hazardous to your health?
(AP)
AP - Could your kitchen at home pass a restaurant inspection?
-
Bone drugs may raise risk of throat cancer
(AP)
AP - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests.
-
Double hand transplant patient shows new hands
(AP)
 AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.
-
Timer may help kids' bladder control problems
(Reuters)
Reuters - Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests.
-
Safety groups find no Pampers link to rash cases
(Reuters)
Reuters - Two agencies investigating claims that Procter & Gamble Co's Pampers Dry Max gave children severe diaper rash reported Thursday that they have found no specific cause linking the diapers to rashes.
-
Study: Diet Drug Meridia May Boost Heart Risks
(Time.com)
Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke
-
Abbott diet drug study renews calls for U.S. ban
(Reuters)
Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
-
Botox maker to pay $600M to resolve investigation
(AP)
 AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
|
